Vr Adviser, LLC Athira Pharma, Inc. Transaction History

Vr Adviser, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.74 - $13.43 $2.74 Million - $13.4 Million	-1,000,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$9.17 - $16.39 $1.8 Million - $3.22 Million	-196,196 Reduced 16.4%	1,000,000 $13 Million
Q3 2021 Nov 15, 2021	SELL	$9.15 - $11.09 $2.64 Million - $3.2 Million	-288,809 Reduced 19.45%	1,196,196 $11.2 Million
Q2 2021 Aug 13, 2021	SELL	$10.24 - $20.87 $2.12 Million - $4.31 Million	-206,618 Reduced 12.21%	1,485,005 $15.2 Million
Q4 2020 Feb 12, 2021	BUY	$16.48 - $34.3 $2.8 Million - $5.83 Million	170,000 Added 11.17%	1,691,623 $57.9 Million
Q3 2020 Nov 16, 2020	BUY	$16.02 - $18.46 $24.4 Million - $28.1 Million	1,521,623 New	1,521,623 $28.1 Million

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.